HGH Fragment 176-191 dosage is commonly reported anecdotally as 200–500 mcg per day by subcutaneous injection, often taken on an empty stomach and sometimes split into two doses, but these protocols have not been validated in human studies. HGH Fragment 176-191 is a synthetic peptide consisting of the terminal 16 amino acids of human growth hormone at its C-terminal end. This 16-amino acid chain was designed to isolate the fat-burning effects of growth hormone without triggering the broader growth and metabolic effects of full HGH therapy.
Scientists developed the peptide to study whether it could help stimulate fat metabolism while avoiding disruptions to blood sugar levels and IGF-1 production, two of the most debated concerns with full HGH use. That makes it especially relevant for health-conscious readers interested in biohacking, fat loss, performance, anti-aging, or weight management who want medically grounded information before considering peptide use.
However, it’s important to note that HGH Fragment 176-191 has never been clinically tested on humans, and the fat-loss evidence available today comes primarily from animal studies or indirect evidence from a modified version known as AOD-9604. For more insights into clinically tested peptide compounds, you can read this dermatologist-approved peptide guide. Below, you’ll get a clear breakdown of what HGH Fragment 176-191 is, how it works, the benefits people claim, dosage practices, safety concerns, legal status, how it compares with related peptides, common myths, and evidence-based alternatives for fat loss.
Quick Takeaways
What it is: A synthetic peptide fragment derived from human growth hormone (amino acids 176–191).
Goal: To promote fat loss without the broader hormonal effects of HGH.
Human research: None. All available data are from animal trials or studies on AOD-9604.
Dosing: Commonly reported protocols suggest 200–500 mcg daily via subcutaneous injection (not scientifically validated).
Risks: Unknown long-term safety, potential glucose disruption, and contamination from unregulated sources.
Table of Contents
How HGH Fragment 176-191 Works
HGH Fragment 176-191 was designed to mimic the specific portion of growth hormone responsible for breaking down fat cells. Its chemical formula is C39H60N8O13, and unlike full HGH, it does not bind completely to growth hormone receptors.
Mechanism of Action
The fragment, designed from the c terminus of human growth hormone, is thought to:
-
Stimulate lipolysis the breakdown and mobilization of stored fat from adipose tissue.
-
Inhibit lipogenesis the formation of new fat cells.
-
Increase beta-3 adrenergic receptor activity, which enhances energy expenditure.
-
Promote fat burning without significantly affecting insulin sensitivity.
Most of these effects were demonstrated in animal studies, primarily involving obese mice, and they point to changes in fat metabolism rather than clear effects in skeletal muscle. For example, a 2001 study by Heffernan et al. found that growth hormone fragments increased fat metabolism and reduced weight gain in obese mice. However, normal-weight mice did not experience fat loss, suggesting the effect may depend on existing metabolic dysfunction.

Does HGH Fragment 176-191 Work?
Evidence from Animal Studies
Rodent studies show that HGH Fragment 176–191 can reduce body fat accumulation in obesity models and potentially stimulate cartilage growth. Some data also suggest the peptide supports fat utilization while preserving lean tissue in animals. This line of research has also been explored as a possible treatment angle for obesity and cartilage-related conditions such as osteoarthritis.
The Human Research GapNo clinical trials have ever been conducted on the unmodified fragment in human test subjects. In contrast, the related compound AOD-9604 underwent six human studies between 2001 and 2007, and while it was found safe and well-tolerated, it failed to produce significant fat loss compared to placebo. The available literature is still indirect and does not validate the unmodified fragment in humans.
This means that claims about HGH Fragment 176–191’s fat-burning abilities in humans remain unproven.
Claimed Benefits of HGH Fragment 176-191
Despite the lack of human data, marketing and online forums often list a wide range of potential benefits. Here’s what’s claimed, along with the evidence behind it:
|
Claimed Benefit |
Evidence Level |
|---|---|
|
Fat loss |
Animal studies only |
|
Enhanced metabolism |
Theoretical (no clinical proof) |
|
Muscle preservation |
No direct evidence |
|
Cartilage or joint support |
|
|
Improved sleep or recovery |
Anecdotal only |
Fat Loss
Advocates claim the peptide accelerates fat breakdown, especially in “stubborn” areas like the abdomen, and discuss it as a tool for weight management. However, no controlled trials support these claims in humans.
Metabolic Enhancement
Some users suggest higher energy or faster metabolism, but these effects are theoretical and unverified.
Muscle Definition
There’s no evidence this research peptide directly builds muscle, though fat loss could improve muscle visibility.

Cartilage Health
A single rabbit study showed increased cartilage production when HGH Fragment was combined with hyaluronic acid. This finding hasn’t been replicated or tested in humans.
Side Effects and Safety Concerns
Because HGH Fragment 176-191 has never been clinically tested in humans, its long-term safety profile is unknown, and available evidence points to related compounds, animal work, and anecdotal reports rather than direct human trials. However, based on that limited information, potential side effects may include:
-
Injection site irritation (redness, itching, tenderness, or pain)
-
Fatigue or drowsiness
-
Possible disruption of glucose and carbohydrate metabolism
-
Increased hunger or short-term blood sugar fluctuations
-
Older research from 1978 found that similar C-terminal HGH fragments caused temporary rises in blood glucose and plasma insulin levels in animals, raising potential concerns about insulin resistance.
-
Contamination and Purity Risks
Unlike claims made online, there is no proof the fragment avoids causing typical HGH related side effects in humans, including concerns tied to diabetes.
Since the peptide is not approved by the FDA for human consumption, most products are sold by unregulated online sources as a research chemical. Poor manufacturing standards can lead to:
-
Bacterial contamination
-
Impurities, incorrect peptide concentration, or incorrect labeling from unregulated sources
-
Dangerous side reactions
Poor-quality products may have a negative impact on safety.
If a peptide turns cloudy when reconstituted, that can be a sign of poor quality or contamination.
HGH Fragment 176-191 Dosage and Administration
There are no official or clinically validated dosing protocols for this peptide, and online recommendations generally cite anecdotal dosing ranges.
|
Protocol Type |
Typical Dosage |
Frequency |
Duration |
|---|---|---|---|
|
General use |
200–500 mcg per dose |
Used as a daily dosing framework in forum protocols |
4–12 weeks |
|
Administration |
Typically injected by subcutaneous administration (abdomen) |
Empty stomach |
Rotate sites |
Note: These listed ranges are anecdotal and not medically verified. Some users split the daily amount into two doses. It is commonly taken on an empty stomach and delayed until after food, especially carbohydrates, to avoid blunting the intended lipolytic effect. Anyone considering peptide use should only do so under licensed medical supervision.
Is HGH Fragment 176-191 Legal?
The legal status of this peptide depends on location and purpose:
United States: Not FDA-approved. Legal only for research use, not human consumption.
Sports: Banned by the World Anti-Doping Agency (WADA) under “growth hormone fragments.”
Compounding Pharmacies: Restricted under FDA guidelines, growth hormone fragments do not qualify for legal compounding exemptions.
In 2024–2025, the FDA issued over 100 warning letters to companies marketing peptides illegally for human use.
HGH Fragment 176-191 vs AOD-9604
|
Feature |
HGH Fragment 176–191 |
AOD-9604 |
|---|---|---|
|
Composition |
16 amino acids (176–191) |
Fragment + extra tyrosine |
|
Human Trials |
None |
|
|
Safety Data |
Unknown |
Safe but ineffective for fat loss |
|
Legal Status |
Not approved |
Not approved, WADA banned |
AOD-9604 was developed as a patentable version of the fragment with slightly improved stability, and it was also studied through oral administration in human trials. Despite undergoing human trials, it did not produce significant weight loss results. That does not validate oral pills of HGH Fragment 176–191 or show they are effective.
Evidence-Based Fat Loss Alternatives
If your goal is safe and sustainable fat loss, evidence backed methods outperform untested peptides:
-
Resistance training builds muscle and increases metabolism.
-
High Protein Diets 2.2–3.0 g/kg of protein preserves muscle while burning fat.
-
Intermittent fasting enhances fat oxidation and improves metabolic flexibility.
-
Sleep Optimization Sleep naturally boosts growth hormone secretion.
-
Moderate Caloric Deficit Gradual fat loss (0.5–1% body weight per week) maintains lean tissue.
-
These approaches are clinically proven, safe, and carry no legal or contamination risks.
Common Myths About HGH Fragment 176-191
“It’s the same as AOD-9604.”
False. AOD-9604 has an extra amino acid and was actually tested in humans. HGH Fragment has not.
“It burns fat without diet or exercise.”
False. Even AOD-9604 showed no results without proper diet and training.
“It’s safer than HGH.”
Unknown. With no human safety data, this claim has no foundation.
“It’s legal because it’s sold online.”
Incorrect. Selling or using it for human purposes violates FDA law.
“It targets stubborn belly fat.”
No scientific evidence supports spot reduction of fat.
The Bottom Line for HGH Fragment 176-191
HGH Fragment 176-191 remains an experimental compound, sold and classified strictly for research purposes, with no verified human research. While early animal studies show potential fat-loss effects, no evidence confirms safety or efficacy in people. Even its modified version, AOD-9604, failed to produce significant weight reduction in clinical settings.
Given the risks of unregulated sources, possible glucose disruption, and lack of long-term safety data, HGH Fragment 176-191 should be approached with extreme caution. Compared with intact hGH, the fragment is often described in preclinical literature as lacking links to insulin resistance or diabetes, but that does not establish human safety. These products are often sold as lyophilized powder and reconstituted with bacteriostatic water or bac water, typically by directing the liquid down the vial wall rather than into the powder, which adds handling and contamination concerns. Even careful sterile technique does not fix the lack of human evidence or safety validation.
For reliable fat loss, focus on evidence-based methods like resistance training, clean nutrition, adequate sleep, and structured calorie control before considering any unapproved peptide therapy.
Read more on Peptides Unleashed blog